| |
| |
|
| Insider
Information: |
Bios Advisors Gp, Llc |
| Relationship: |
Director, 10% Owner |
| City: |
Fort Worth |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
5,023,852 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
5,023,852 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lantern Pharma Inc. |
LTRN |
10% Owner |
|
0 |
2024-02-29 |
753,428 |
Premium* |
|
|
In8bio, Inc. |
INAB |
Director, 10% Owner |
2021-08-03 |
0 |
2022-12-12 |
4,270,424 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LTRN |
Lantern Pharma Inc. |
10% Owner |
– – • |
2024-02-29 |
4 |
S |
$4.87 |
$95,954 |
I/I |
(19,703) |
137,832 |
0 |
- |
|
| LTRN |
Lantern Pharma Inc. |
10% Owner |
– – • |
2024-02-28 |
4 |
S |
$4.85 |
$360,340 |
I/I |
(74,297) |
142,017 |
0 |
- |
|
| LTRN |
Lantern Pharma Inc. |
10% Owner |
– – • |
2024-02-27 |
4 |
S |
$4.40 |
$220,000 |
I/I |
(50,000) |
157,797 |
0 |
- |
|
| LTRN |
Lantern Pharma Inc. |
10% Owner |
– – • |
2024-01-17 |
4 |
S |
$4.20 |
$247,334 |
I/I |
(58,889) |
168,417 |
0 |
- |
|
| LTRN |
Lantern Pharma Inc. |
10% Owner |
– – • |
2024-01-17 |
4 |
OE |
$3.13 |
$247,336 |
I/I |
79,021 |
180,938 |
0 |
- |
|
| LTRN |
Lantern Pharma Inc. |
10% Owner |
– – • |
2023-11-29 |
4 |
S |
$3.44 |
$499,997 |
I/I |
(145,348) |
371,950 |
0 |
- |
|
| INAB |
In8bio, Inc. |
Director |
– • • |
2022-12-12 |
4 |
B |
$2.48 |
$185,912 |
I/I |
75,001 |
570,724 |
2.25 |
- |
|
| LTRN |
Lantern Pharma Inc. |
10% Owner |
– – • |
2022-11-08 |
4 |
S |
$4.40 |
$1,540,000 |
I/I |
(350,000) |
164,137 |
0 |
- |
|
| INAB |
In8bio, Inc. |
Director |
– • • |
2022-09-28 |
4 |
B |
$2.02 |
$50,535 |
I/I |
25,000 |
561,989 |
2.25 |
- |
|
| LTRN |
Lantern Pharma Inc. |
10% Owner |
– – • |
2022-09-02 |
4 |
S |
$5.20 |
$33,514 |
I/I |
(6,445) |
26,093 |
0 |
- |
|
| LTRN |
Lantern Pharma Inc. |
10% Owner |
– – • |
2022-09-02 |
4 |
OE |
$1.03 |
$33,514 |
I/I |
32,538 |
27,328 |
0 |
- |
|
| INAB |
In8bio, Inc. |
Director |
– • • |
2022-08-17 |
4 |
B |
$1.93 |
$96,500 |
I/I |
50,000 |
553,110 |
2.25 |
- |
|
| INAB |
In8bio, Inc. |
Director |
– • • |
2022-08-16 |
4 |
B |
$1.90 |
$3,370,000 |
I/I |
1,773,684 |
540,287 |
2.25 |
- |
|
| INAB |
In8bio, Inc. |
10% Owner |
– – • |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
6,625,102 |
359,374 |
0 |
- |
|
| LTRN |
Lantern Pharma Inc. |
10% Owner |
– – • |
2020-06-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,456,648 |
89,522 |
0 |
- |
|
| LTRN |
Lantern Pharma Inc. |
10% Owner |
– – • |
2020-06-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
304,498 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
